Market Value439,278,544
Total Holdings72
File Date2024-05-15
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CGEN / Compugen Ltd.
MASI / Masimo Corporation
MRUS / Merus N.V.
ARAY / Accuray Incorporated
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BCRX / BioCryst Pharmaceuticals, Inc.
APRE / Aprea Therapeutics, Inc.
INGN / Inogen, Inc.
EWTX / Edgewise Therapeutics, Inc.
DXCM / DexCom, Inc.
VKTX / Viking Therapeutics, Inc.
SPRO / Spero Therapeutics, Inc.
ISR / Perspective Therapeutics Inc
ELEV / Elevation Oncology, Inc.
IPSC / Century Therapeutics, Inc.
SAGE / Sage Therapeutics, Inc.
PYPD / PolyPid Ltd.
NVRO / Nevro Corp.
CYTK / Cytokinetics, Incorporated
CMPS / COMPASS Pathways plc - Depositary Receipt (Common Stock)
SLRN / Acelyrin, Inc.
AXGN / Axogen, Inc.
GOSS / Gossamer Bio, Inc.
ALEC / Alector, Inc.
MLYS / Mineralys Therapeutics, Inc.
RGLS / Regulus Therapeutics Inc.
TSVT / 2seventy bio, Inc.
ATRC / AtriCure, Inc.
CMPX / Compass Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
KPTI / Karyopharm Therapeutics Inc.
AMLX / Amylyx Pharmaceuticals, Inc.
MREO / Mereo BioPharma Group plc - Depositary Receipt (Common Stock)
IMGN / ImmunoGen, Inc.
ARGX / argenx SE - Depositary Receipt (Common Stock)
MRTX / Mirati Therapeutics, Inc.
MGNX / MacroGenics, Inc.
CGEM / Cullinan Therapeutics, Inc.
SPRB / Spruce Biosciences, Inc.
KNTE / Kinnate Biopharma Inc.
STXS / Stereotaxis, Inc.
VIGL / Vigil Neuroscience, Inc.
ITOS / iTeos Therapeutics, Inc.
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
RVMD / Revolution Medicines, Inc.
IMTX / Immatics N.V.
BHVN / Biohaven Ltd.
STRO / Sutro Biopharma, Inc.
PRQR / ProQR Therapeutics N.V.
PODD / Insulet Corporation
LRMR / Larimar Therapeutics, Inc.
BPMC / Blueprint Medicines Corporation
VTGN / Vistagen Therapeutics, Inc.
ACET / Adicet Bio, Inc.
ANRO / Alto Neuroscience, Inc.
SPRY / ARS Pharmaceuticals, Inc.
ACRV / Acrivon Therapeutics, Inc.
MORF / Morphic Holding, Inc.
KRTX / Karuna Therapeutics, Inc.
ORIC / ORIC Pharmaceuticals, Inc.
MDWD / MediWound Ltd.
SYRS / Syros Pharmaceuticals, Inc.
PRCT / PROCEPT BioRobotics Corporation
STIM / Neuronetics, Inc.
NBIX / Neurocrine Biosciences, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
BNTX / BioNTech SE - Depositary Receipt (Common Stock)
ATXS / Astria Therapeutics, Inc.
GLPG / Galapagos NV - Depositary Receipt (Common Stock)
BCYC / Bicycle Therapeutics plc - Depositary Receipt (Common Stock)
IDYA / IDEAYA Biosciences, Inc.
XENE / Xenon Pharmaceuticals Inc.
AQST / Aquestive Therapeutics, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
KALV / KalVista Pharmaceuticals, Inc.
XBI / SPDR Series Trust - SPDR S&P Biotech ETF
STOK / Stoke Therapeutics, Inc.
KURA / Kura Oncology, Inc.
RCUS / Arcus Biosciences, Inc.
BWAY / BrainsWay Ltd. - Depositary Receipt (Common Stock)
DAWN / Day One Biopharmaceuticals, Inc.
IMVT / Immunovant, Inc.
TNDM / Tandem Diabetes Care, Inc.
KROS / Keros Therapeutics, Inc.
IBB / iShares Trust - iShares Biotechnology ETF
LCTX / Lineage Cell Therapeutics, Inc.